161 related articles for article (PubMed ID: 21329432)
21. Proteomic analysis of traumatic brain injury: the search for biomarkers.
Prieto DA; Ye X; Veenstra TD
Expert Rev Proteomics; 2008 Apr; 5(2):283-91. PubMed ID: 18466057
[TBL] [Abstract][Full Text] [Related]
22. Proteomics technologies for biomarker discovery in multiple sclerosis.
Singh V; Hintzen RQ; Luider TM; Stoop MP
J Neuroimmunol; 2012 Jul; 248(1-2):40-7. PubMed ID: 22129845
[TBL] [Abstract][Full Text] [Related]
23. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
Mischak H; Delles C; Klein J; Schanstra JP
Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
[TBL] [Abstract][Full Text] [Related]
24. [Differential diagnosis of psychopathy and autism spectrum disorders in adults. Empathic deficit as a core symptom].
Hansman-Wijnands MA; Hummelen JW
Tijdschr Psychiatr; 2006; 48(8):627-36. PubMed ID: 16958304
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with the diagnosis of neurodevelopmental disorders: a population-based longitudinal study.
Chen CY; Liu CY; Su WC; Huang SL; Lin KM
Pediatrics; 2007 Feb; 119(2):e435-43. PubMed ID: 17272605
[TBL] [Abstract][Full Text] [Related]
26. Recent cerebrospinal fluid biomarker studies of Alzheimer's disease.
Choi YS; Choe LH; Lee KH
Expert Rev Proteomics; 2010 Dec; 7(6):919-29. PubMed ID: 21142892
[TBL] [Abstract][Full Text] [Related]
27. High-performance proteomics as a tool in biomarker discovery.
Meyer HE; Stühler K
Proteomics; 2007 Sep; 7 Suppl 1():18-26. PubMed ID: 17893859
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery.
Fang X; Balgley BM; Lee CS
Electrophoresis; 2009 Dec; 30(23):3998-4007. PubMed ID: 19960464
[TBL] [Abstract][Full Text] [Related]
29. [Rehabilitation! Diagnosis can be a turning point for adults with ADHD/autism spectrum disorders].
Bejerot S
Lakartidningen; 2004 Oct; 101(42):3222-3. PubMed ID: 15544125
[No Abstract] [Full Text] [Related]
30. Biomarker discovery in psychiatric disorders.
Schwarz E; Bahn S
Electrophoresis; 2008 Jul; 29(13):2884-90. PubMed ID: 18512679
[TBL] [Abstract][Full Text] [Related]
31. The molecular make-up of a tumour: proteomics in cancer research.
Kolch W; Mischak H; Pitt AR
Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
[TBL] [Abstract][Full Text] [Related]
32. [Child-adolescent psychiatry to adult psychiatry: can we find those disorders in adulthood which are typically diagnosed in childhood?].
Balázs J; Gádoros J; Prekop C
Neuropsychopharmacol Hung; 2009 Sep; 11(3):151-9. PubMed ID: 20128394
[TBL] [Abstract][Full Text] [Related]
33. New directions of miniaturization within the biomarker research area.
Marko-Varga GA; Nilsson J; Laurell T
Electrophoresis; 2004 Nov; 25(21-22):3479-91. PubMed ID: 15565715
[TBL] [Abstract][Full Text] [Related]
34. Biomarker discovery: validation and decision-making in product development.
Niedbala RS; Mauck C; Harrison P; Doncel GF
Sex Transm Dis; 2009 Mar; 36(3 Suppl):S76-80. PubMed ID: 19218888
[TBL] [Abstract][Full Text] [Related]
35. Proteomics in atherothrombosis: a future perspective.
Martín-Ventura JL; Blanco-Colio LM; Tunon J; Gomez-Guerrero C; Michel JB; Meilhac O; Egido J
Expert Rev Proteomics; 2007 Apr; 4(2):249-60. PubMed ID: 17425460
[TBL] [Abstract][Full Text] [Related]
36. Children with attention-deficit/hyperactivity disorder and autistic features: EEG evidence for comorbid disorders.
Clarke AR; Barry RJ; Irving AM; McCarthy R; Selikowitz M
Psychiatry Res; 2011 Jan; 185(1-2):225-31. PubMed ID: 20580838
[TBL] [Abstract][Full Text] [Related]
37. Structural brain abnormalities in adolescents with autism spectrum disorder and patients with attention deficit/hyperactivity disorder.
Brieber S; Neufang S; Bruning N; Kamp-Becker I; Remschmidt H; Herpertz-Dahlmann B; Fink GR; Konrad K
J Child Psychol Psychiatry; 2007 Dec; 48(12):1251-8. PubMed ID: 18093031
[TBL] [Abstract][Full Text] [Related]
38. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
39. CE-MS in biomarker discovery, validation, and clinical application.
Mischak H; Schanstra JP
Proteomics Clin Appl; 2011 Feb; 5(1-2):9-23. PubMed ID: 21280234
[TBL] [Abstract][Full Text] [Related]
40. Proteomic methods for biomarker discovery in urine.
Wilkey DW; Merchant ML
Semin Nephrol; 2007 Nov; 27(6):584-96. PubMed ID: 18061841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
